Position in GH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,589,662
+$19,332,673 QoQ
Shares Held
337,197
-0.4% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#71
of 593 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026RAYMOND JAMES FINANCIAL INC holds $1,810,723,119 across 28 Diagnostics & Research names. GH ranks #11 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
779,661 | $390,890,837 | |
| 2 | DHR |
Danaher Corp /De/
|
1,515,515 | $288,675,296 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
1,037,428 | $200,451,836 | |
| 4 | NTRA |
Natera, Inc.
|
593,083 | $160,992,378 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
262,791 | $138,343,692 | |
| 6 | DGX |
Quest Diagnostics Inc
|
505,762 | $107,196,254 | |
| 7 | A |
Agilent Technologies, Inc.
|
636,252 | $84,513,350 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
126,182 | $66,824,723 |
All Filings in GH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,589,662 | 337,197 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $31,256,989 | 338,389 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $33,566,471 | 328,632 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $20,611,713 | 329,893 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $12,104,449 | 232,599 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,704,630 | 63,489 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,210,719 | 72,364 | Shares | Defined | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||